ALINE SCHOTTE PHARMA
The computed 12-month bankruptcy probability of ALINE SCHOTTE PHARMA is 0.4% (very low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 1 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Limited partnership(612) |
| Incorporation | 11-03-2025 |
| Status | Active |
| Postal code | 8900 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33011C0088/00F000 | Flanders | 1,106 m² | 1 · 181 m² | 13.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
20-06-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Loker",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-06-20",
"filing_date": "2025-06-12",
"act_kind_objet": "Statutenwijziging"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-20",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "1020.875.015",
"name": "ALDELMY-LEPE",
"role": "contributor",
"address": "Meenseweg 224, 8900 leper",
"is_foreign": false,
"legal_form": "Commanditaire vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"10"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 100,
"real_estate_included": false,
"patrimony_description": "De vennootschap ontvangt \u20AC 100,00 aan inbrengen, vertegenwoordigd door 100 aandelen op naam.",
"equity_transferred_eur": 100.0,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "1020.875.015",
"name_full": "ALDELMY-LEPE",
"legal_form": "Commanditaire vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Rudi Blanckaert",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van ONDERNEMINGSRECHTBANK aldelmy-lepe, gehouden op 17 mei 2025, heeft besloten tot een wijziging van de statuten, met name van artikel 5 en 8. Hierbij worden de passussen die bepaalde aandeelhouders uitsluiten van winstrechten, voor niet geschreven en dus onbestaande, gehouden. De vergadering verleent ook een volmacht aan Rudi Blanckaert en medewerkers van BLANCKAERT ACCOUNTANCY voor de bekendmaking en publicatie van een uittreksel van de notulen in het Belgisch Staatsblad.",
"co_filed_documents": [
"originele notulen van de buitengewone algemene vergadering dd. 17 mei 2025",
"dadingsovereenkomst dd. 17 mei 2025",
"tekst van de geco\u00F6rdineerde statuten dd. 17 mei 2025"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ALINE SCHOTTE PHARMA |